Menu
Back to User profile » Dr Henan Li
Papers published by Dr Henan Li:
In vitro Synergistic Activity of Ceftazidime-Avibactam in Combination with Aztreonam or Meropenem Against Clinical Enterobacterales Producing blaKPC or blaNDM
Kuai J, Zhang Y, Lu B, Chen H, Zhang Y, Li H, Wang Y, Wang Q, Wang H, Wang X
Infection and Drug Resistance 2023, 16:3171-3182
Published Date: 23 May 2023
Antimicrobial Resistance Trends of the Most Common Causative Pathogens Associated with Community-acquired Respiratory Infections in China: 2009–2018
Zhao C, Yang S, Zhang F, Wang Z, Zhang Y, Wang X, Li H, Chen H, Wang H
Infection and Drug Resistance 2022, 15:5069-5083
Published Date: 31 August 2022
Evolution of Acinetobacter baumannii in Clinical Bacteremia Patients
Li H, Zhang J, Wang Z, Yin Y, Gao H, Wang R, Jin L, Wang Q, Zhao C, Wang Z, Wang H
Infection and Drug Resistance 2021, 14:3553-3562
Published Date: 31 August 2021
Investigation of Antibiotic Resistance, Serotype Distribution, and Genetic Characteristics of 164 Invasive Streptococcus pneumoniae from North China Between April 2016 and October 2017
Zhao C, Xie Y, Zhang F, Wang Z, Yang S, Wang Q, Wang X, Li H, Chen H, Wang H
Infection and Drug Resistance 2020, 13:2117-2128
Published Date: 3 July 2020
A multicenter epidemiology study on the risk factors and clinical outcomes of nosocomial intra-abdominal infections in China: results from the Chinese antimicrobial resistance surveillance of nosocomial infections (CARES) 2007–2016
Zhang J, Zhao C, Chen H, Li H, Wang Q, Wang Z, Zhang F, Wang H
Infection and Drug Resistance 2018, 11:2311-2319
Published Date: 15 November 2018
Defining the potency of amikacin against Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii derived from Chinese hospitals using CLSI and inhalation-based breakpoints
Kuti JL, Wang Q, Chen H, Li H, Wang H, Nicolau DP
Infection and Drug Resistance 2018, 11:783-790
Published Date: 25 May 2018